
X4 Pharmaceuticals, Inc.
USD3.63
-0.06 (-1.49%)
CEO
Adam R. Craig
IPO Date
2017-11-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.68
Prev. Close
$3.68
Day Low
$3.63
Day High
$3.77
52W Low
$1.35
52W High
$4.83
Market Cap
$0.34B
Volume
0.16M
X4 Pharmaceuticals Announces Positive Preliminary Data from Ongoing Phase 1b Clinical Trial of Mavorixafor in Waldenström's Macroglobulinemia as Published in EHA Abstract